You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure ○

found 2025 › Mar › 25 (Tue) @ 07:00 UTC

a story from CNBC ⚠️ › World News

○ Neutral overall

0.00 negativity

0.00 neutrality

0.00 positivity